A newly developed microfluidic biosensor promises to reshape how CD4+ T cells — key indicators of immune function in Human Immunodeficiency Virus (HIV) patients — are detected. By integrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results